SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
L'Oréal S.A. (LRLCY) trades at a trailing P/E of 37.1, forward P/E of 31.4. Trailing earnings yield is 2.70%, forward earnings yield 3.19%. PEG 1.73.
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 31.4 (down from trailing 37.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.73 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 2.70% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.19% as earnings recover.
Overall SharesGrow Score: 62/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LRLCY
Valuation Multiples
P/E (TTM)37.1
Forward P/E31.4
PEG Ratio1.73
Forward PEG1.73
P/B Ratio0.00
P/S Ratio5.16
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.29
Forward EPS (Est.)$2.70
Book Value / Share$0.00
Revenue / Share$16.46
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.70%
Forward Earnings Yield3.19%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.09 |
$24.92B |
$3.11B |
12.5% |
| 2017 |
$1.36 |
$26.02B |
$3.58B |
13.8% |
| 2018 |
$1.38 |
$26.94B |
$3.9B |
14.5% |
| 2019 |
$1.33 |
$29.87B |
$3.75B |
12.6% |
| 2020 |
$1.27 |
$27.99B |
$3.56B |
12.7% |
| 2021 |
$1.64 |
$32.29B |
$4.6B |
14.2% |
| 2022 |
$2.12 |
$38.26B |
$5.71B |
14.9% |
| 2023 |
$2.30 |
$41.18B |
$6.18B |
15% |
| 2024 |
$2.39 |
$43.49B |
$6.41B |
14.7% |
| 2025 |
$2.29 |
$44.05B |
$6.13B |
13.9% |
